Shanchao Zhao

17PUBLICATIONS
152CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 12, 2026
Tumor-derived CTHRC1 mediates ITGB3-dependent osteoclast differentiation to promote prostate cancer bone metastasis.

|Aug 07, 2026
APOE+ macrophages and POSTN+CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma.

|Jul 01, 2026
FOXQ1 activates GLT8D2 to enhance CCL2 N-glycosylation and promote prostate cancer bone metastasis.

|Feb 17, 2026
The FOSB-IGFBP5-IGF-1 axis: a novel regulatory pathway that suppresses prostate cancer growth.

Jun Huang, Sheng-Dong Ge, Ling-Lan Zhao

|Nov 02, 2025
CAD is Associated with Cancer Prognosis and Promotes Enzalutamide Resistance in Prostate Cancer.

Bing-Xue Ma, Yi-You Mao, Ze-Fan Zhang

|Aug 07, 2025
Automatic recognition of adrenal incidentalomas using a two-stage cascade network: a multicenter study.

Xiao Xie, Sheng-Xiao Ma, Xiang-De Luo

Pageof 3

Frequent Collaborators

3 joint publications

Mingkun Chen

2 joint publications

Zhe-Sheng Chen

2 joint publications

Ninghan Feng

2 joint publications

Zhiyue Xie